
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial
Keywords: مقدار جذب استاندارد شده; FDG; Inflammation; Atherosclerosis; MAPK; Imaging; 18FDG; 18F-fluorodeoxyglucose; hs-CRP; high sensitivity C-reactive peptide; MAPK; mitogen-activated protein kinase; PET; positron emission tomography; ROI; region of interest; SUV; standardized uptake val